7.
Networks for outcome 'All adverse events'. Colours distinguish the separate networks. There are three networks, one with levosimendan/placebo/milrinone/milrinone ld/dobutamine, one with milrinone + dobutamine versus levosimendan + dobutamine, and one with levosimendan + milrinone + dopamine versus milrinone + dopamine.
Abbreviation(s) LD: low‐dose